Pfizer's anti-Covid pill Paxlovid could be available in India next week

This assumes significance as Covid cases are on the rise in the country, especially in the National Capital Region (NCR)

Doctors are hopeful that Pfizer’s anti-Covid oral drug Paxlovid, which is expected to be available this week in India, is likely to play a key role if Covid19 cases rise in India due to the new Omicron sub-lineage.

Hyderabad-based Hetero has already received the DCGI approval to launch the drug in India on April 21, and sources indicated that the drug may be available as soon as this week across the country.

The pricing in India is expected to be competitive, but Hetero has not disclosed the pricing of their version of Pfizer’s oral drug – a combination therapy of nirmatrelvir and